Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal haemorrhage, Tinnitus
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of PHARYNGEAL HAEMORRHAGE (after clearing her throat, produced pancake sized blood clots), INTERNAL HAEMORRHAGE (blood from many different places, 2 episodes of bad bleeding) and EPISTAXIS (her nose started pouring blood. She felt it was far up her face and she was drowning in blood) in a 52-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 003K21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 27-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 27-Feb-2022, the patient experienced TINNITUS (ears started ringing). On 28-Feb-2022, the patient experienced DIZZINESS (Dizzy). On 01-Mar-2022, the patient experienced PHARYNGEAL HAEMORRHAGE (after clearing her throat, produced pancake sized blood clots) (seriousness criterion hospitalization). 01-Mar-2022, the patient experienced EPISTAXIS (her nose started pouring blood. She felt it was far up her face and she was drowning in blood) (seriousness criterion hospitalization). On an unknown date, the patient experienced INTERNAL HAEMORRHAGE (blood from many different places, 2 episodes of bad bleeding) (seriousness criterion hospitalization), EAR HAEMORRHAGE (she had blood in her ears) and EYE HAEMORRHAGE (was crying tears of blood). The patient was hospitalized from sometime in March 2022 to sometime in March 2022 due to EPISTAXIS, INTERNAL HAEMORRHAGE and PHARYNGEAL HAEMORRHAGE. On 27-Feb-2022, TINNITUS (ears started ringing) had resolved. At the time of the report, PHARYNGEAL HAEMORRHAGE (after clearing her throat, produced pancake sized blood clots), INTERNAL HAEMORRHAGE (blood from many different places, 2 episodes of bad bleeding), EPISTAXIS (her nose started pouring blood. She felt it was far up her face and she was drowning in blood), EAR HAEMORRHAGE (she had blood in her ears) and EYE HAEMORRHAGE (was crying tears of blood) had resolved and DIZZINESS (Dizzy) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication details was provided. Patient had received a single dose of the Moderna Covid-19 vaccine. 30 minutes after received the vaccine her ears started ringing, but then that went away within a couple hours. The next morning on 1MAR2022 her nose started pouring blood. She felt it was far up her face and she was drowning in blood. It was intermittent but after clearing her throat she produced pancake sized blood clots. She had to call an aid car who took her to a hospital because they were not able to stop the bleeding. While in the hospital (started 1st or 2nd of March as it was close to midnight). She had doctors tried to cauterize the bleeding, however there was blood from many different places limiting the ability to cauterize. She was given a nose spray which did not help. She then had balloons inserted into her face to slow the bleeding. She was sent home after 4 days in the hospital. She had times where she had blood in her ears and was crying tears of blood. She had continued to have some bleeding up until previous day of reporting. Company comment: This spontaneous case concerns a 52-year-old female patient, with no medical history reported, who experienced the serious (hospitalization) unexpected events of epistaxis, pharyngeal haemorrhage and internal haemorrhage, which occurred 3 days after a dose of mRNA-1273. The patient was hospitalized 3 days for treatment. No blood tests reported. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Sender's Comments: This spontaneous case concerns a 52-year-old female patient, with no medical history reported, who experienced the serious (hospitalization) unexpected events of epistaxis, pharyngeal haemorrhage and internal haemorrhage, which occurred 3 days after a dose of mRNA-1273. The patient was hospitalized 3 days for treatment. No blood tests reported. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.